Published in Toxicol Appl Pharmacol on April 01, 2004
Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ Health Perspect (2005) 1.11
PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas. Br J Cancer (2007) 1.02
Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001-2006). Environ Health Perspect (2014) 0.94
Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output. Clin Exp Metastasis (2005) 0.89
Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites. Toxicol Appl Pharmacol (2007) 0.87
Estrogenic Activity of Mineral Oil Aromatic Hydrocarbons Used in Printing Inks. PLoS One (2016) 0.80
Assessing indoor air exposures using passive sampling with bioanalytical methods for estrogenicity and aryl hydrocarbon receptor activity. Anal Bioanal Chem (2009) 0.77
Synthetic musk fragrances in human milk from the United States. Environ Sci Technol (2007) 1.55
The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. Small (2010) 1.43
Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Mol Cancer Res (2006) 1.24
Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish. Small (2010) 1.16
Perfluorinated compounds in human milk from Massachusetts, U.S.A. Environ Sci Technol (2008) 1.05
Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res (2003) 1.04
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst (2012) 1.02
Phenotypic changes in MCF-7 cells during prolonged exposure to tamoxifen. Mol Cell Endocrinol (2003) 0.98
The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. J Cell Biochem (2013) 0.93
Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics (2012) 0.92
Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics (2010) 0.90
Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis (2003) 0.89
Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics (2011) 0.89
Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites. Toxicol Appl Pharmacol (2007) 0.87
Transcriptional regulation of rat CYP2A3 by nuclear factor 1: identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo. J Biol Chem (2004) 0.85
Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II. Am J Epidemiol (2015) 0.84
Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol (2009) 0.83
Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs. Environ Mol Mutagen (2007) 0.83
Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions of CYP1B1 and CYP1A1 genes. Mol Carcinog (2003) 0.82
Effects of polycyclic aromatic hydrocarbon-containing oil mixtures on generation of reactive oxygen species and cell viability in MCF-7 breast cancer cells. J Toxicol Environ Health A (2007) 0.81
Mechanisms of arsenite-mediated decreases in benzo[k]fluoranthene-induced human cytochrome P4501A1 levels in HepG2 cells. Drug Metab Dispos (2004) 0.81
Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy. BMC Cancer (2012) 0.81
Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. J Steroid Biochem Mol Biol (2008) 0.80
Potential of using breast milk as a tool to study breast cancer and breast cancer risk. Future Oncol (2008) 0.79
Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors. Epigenetics (2015) 0.79
Investigations of the posttranslational mechanism of arsenite-mediated downregulation of human cytochrome P4501A1 levels: the role of heme oxygenase-1. J Biochem Mol Toxicol (2009) 0.79
SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. J Cell Physiol (2014) 0.78
Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis. Cancer Causes Control (2015) 0.77
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers. Cancer Cell Int (2012) 0.77
Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics. Adv Exp Med Biol (2014) 0.75
Effects of exposure water volume, depuration time, and feeding status on vitellogenin mRNA induction in male medaka (Oryzias latipes) exposed to 17 β-estradiol. Ecotoxicol Environ Saf (2010) 0.75